Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension (NOH302)
NCT00633880Phase 3Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Jan 2008
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of droxidopa in Neurogenic Orthostatic Hypotension (nOH), sponsored by Chelsea Therapeutics International, Ltd.. Started Jan 2008; status: completed.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00633880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633880.